Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bugan Shengsheng Tang is a traditional Chinese medicine (TCM) herbal formula used primarily in the management of liver diseases, particularly acute-on-chronic liver failure (ACLF) and chronic or acute liver failure. The formula is often studied and administered in combination with artificial liver support therapies such as DPMAES (double plasma molecular adsorption system) and PDF (plasma diafiltration). Its mechanism of action is based on TCM principles, aiming to "nourish the liver" and promote regeneration, though specific molecular targets are not well characterized in Western pharmacological terms. Clinical studies suggest that Bugan Shengsheng Tang may improve clinical outcomes when combined with artificial liver treatments[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bugan Shengsheng Tang.